Ardelyx, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutics focuses on addressing cardiorenal and gastrointestinal (GI) diseases.

David Rosenbaum
Chief Development Officer
Elizabeth Grammer
Chief Legal and Administrative Officer
Jeff Jacobs
Chief Scientific Officer
Justin Renz
Chief Financial Officer
Robert Blanks
Chief Regulatory Affairs and Quality Assurance Officer
Susan Rodriguez
Chief Commercial Officer
Laura Williams
SVP, Global Therapeutic Strategies & Patient Advocacy

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.